AAREYDRUGS
NSEAarey Drugs & Pharmaceuticals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹82.83
1.69 (2.00%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹235 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
56.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹50.31+64.6%
52W High₹100-17.2%
Current Price
₹82.83
Circuit Limits (2%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹81.17
Upper Circuit₹84.49
Reference Price
₹82.83
Investment Checklist
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹85.46
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹85.38
20/50 Bullish Cross detected 2 day(s) ago
EMA(50) Crossover: Price crossed below EMA(50): Fresh bearish weakness signal.
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
46%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)
EMA20
85.45
EMA50
83.15
EMA200
78.19
Price Action
DOWNTREND
BEARISH
Higher Highs2
Higher Lows2
Lower Highs7
Lower Lows7
Support & Resistance Levels
Resistance (Above)
₹86.37
₹92.63
₹96.00
₹100.00
Support (Below)
₹81.00
₹79.71
₹74.41
₹73.07
₹72.00
Volume Analysis
TrendDECREASING
Change-75.80%
Unusual VolumeNo
Recent MA Crossovers
20/50 Bullish Cross
2 days ago
BUY
Recent Price Gaps
Gap Down
1 day ago • 2.00%
BEARISH
Gap Down
2 days ago • 1.99%
BEARISH
Stop Loss Levels
Fixed Risk
1% Risk₹82.00
3% Risk₹80.35
5% Risk₹78.69
7% Risk (Custom)
₹77.03Technical Levels
1x ATR (Volatility)₹79.73
2x ATR (Swing)₹76.63
3x ATR (Trend)₹73.53
Immediate Support₹81.00
Moving Averages
EMA 200 (Long-term)₹78.19
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹133.8 Cr | ₹106.4 Cr | ₹102.2 Cr | ₹84.2 Cr |
| Net Profit | ₹71,80,000 | ₹47,01,000 | ₹1.4 Cr | ₹1 Cr |
| EPS | ₹0.26 | — | ₹0.48 | ₹0.36 |
| Operating Profit | ₹2.9 Cr | ₹2.6 Cr | ₹3.3 Cr | ₹3.4 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Aarey Drugs & Pharmaceuticals Limited | ₹82.83 | -2.00% | 56.9 | ₹235 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 23 Sept 2024 | Annual General Meeting | AGM |
| 29 Aug 2023 | Annual General Meeting | AGM |
| 22 Sept 2022 | Annual General Meeting | AGM |
| 02 Sept 2021 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for AAREYDRUGS
View All
positive
ET Markets - Industry 7d ago
Sun Pharma secures relief in 'Pantocid' trademark dispute
Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.
AAREYDRUGSABGSECAKUMSSPARCFinancial ServicesHealthcare
positive
CNBC TV18 - Markets 51d ago
Akums Drugs, subsidiary Akumentis Healthcare face ₹134 crore Income Tax demand
Shares of Akums Drugs and Pharmaceuticals Ltd ended at ₹513.00, down by ₹6.70, or 1.29%, on the BSE.
AAREYDRUGSAKUMSBSEHCGHCG-REHEALTHCAREMOHEALTHFinancial ServicesHealthcare